EU and EUREKA Launched Eurostars Programme for Research-Performing SMEs

EurostarsEurope has taken "another step in the realisation of the European Research Area, this time to the benefit of SMEs", according to EU Science and Research Commissioner Janez Potocnik, who helped to launch EUREKA's Eurostars programme. The programme will provide financial support, from both EU and the EUREKA member country funds, to Europe's young and innovative companies, described by Mr Potocnik as the 'lifeblood' of Europe's economy. The programme is aimed specifically at a niche market of research and innovation-performing businesses that fulfil the EU-adopted definition of an SME, are based in a country participating in Eurostars, and that invest 10% or more of their annual turnover in research.

"SMEs are the driving motor of the European economy because they are flexible. They can adapt quickly to the needs of the market," said the Commissioner.

Importantly, the initiative has been welcomed by the SME community. Speaking at the launch, chairman of the European Federation of high-tech SMEs, Emmanuel Leprince, spoke of his 'high expectations' for the programme. He also talked of a 'glass ceiling' that is preventing most SMEs from reaching their full potential. Eurostars will help these young companies, so often considered by investors as the 'dangerous option', to get a foot on the ladder.

The attraction of Eurostars is that it is designed specifically for SMEs involved in research, said Mr Leprince. "The Commission tackles red tape, regulations, standards etc. These are all important issues, but they are not the specific problems of SMEs," he explained.

Some SME representatives would however like to see the criteria for participation widened so that more companies can benefit. Ullrich Schröder, research and development (R&D) advisor at the European craft and SME employers' organisation (UEAPME), said that the number of SMEs investing 10% or over in research is quite small, and that the barrier should be lowered to 5% in line with the definition of a high-tech SME used by the Organisation for Economic Cooperation and Development (OECD).

Representing the Slovenian Presidency of EUREKA, Ales Mihelic, General Director of the Slovenian Ministry of Higher Education, Science and Technology, conceded that 10% is quite high, but pointed out that EUREKA has made it easier for more companies to participate by saying that they can also invest 10% of their full-time equivalent (FTE) in R&D.

Mr Potocnik highlighted how Eurostars will complement existing EU initiatives intended to support SMEs conducting research. Under the Sixth Framework Programme (FP6) the Commission set the target of having SMEs make up 15% of project participants. This target proved difficult to meet in some areas however. Under FP7, the Commission has simplified administrative procedures, increased the funding of SME projects from 50% to 75% of the project's cost, and introduced the guarantee fund. All of these measures are intended to make it easier for SMEs to participate in FP7.

But as the Commissioner pointed out, "In FP7 Cooperation projects, SMEs aren't usually leading the projects." Eurostars will enable SMEs to do just that, benefitting from €100 million in Commission funding and €300 million from 22 EU Member States and five countries associated to FP7. This capital is expected to attract a further €400 million in private investment.

"Eurostars fills a gap that was existing, using tools that were on our market but not used in this combination," said Mr Potocnik. The Commission's participation comes under Article 169 of the EU Treaty, which allows for the participation of the Community in research programmes run jointly by a number of EU Member States.

The Commissioner referred to these new and closer links between EUREKA and the framework programmes as a marriage. Alluding to questions over the Commission's commitment to funding Eurostars beyond its initial six-year timeframe, he said: "As we all know, in a marriage, it is not enough to say 'yes' only at the beginning. You have to show that you mean it constantly."

The imagery continued as the Commissioner concluded his speech, claiming that he was happy to be the best man at this marriage, and wishing Eurostars a long and happy life, with lots of healthy SMEs.

For further information, please visit:
http://www.eurostars-eureka.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...